Abstract
Copper was added to truncated, recombinant cystathionine β-synthase (CBS), and the enzyme activity was assessed by measuring the production of cystathionine. 10microM copper significantly decreased CBS activity by 50% while 25microM copper decreased CBS activity by 70%. This inhibition was negated when an analog of the N-terminus of human albumin, Asp-Ala-His-Lys (DAHK), a strong transition metal binding peptide, was added. The use of copper chelators could significantly reduce in vivo homocysteine levels.
Keywords: cystathionine synthase, inhibition, copper, chelation, homocysteine
Protein & Peptide Letters
Title: Inhibitory Effect of Copper on Cystathionine β-Synthase Activity: Protective Effect of an Analog of the Human Albumin N-Terminus
Volume: 12 Issue: 3
Author(s): David Bar-Or, Leonard T. Rael, Gregory W. Thomas and Jan P. Kraus
Affiliation:
Keywords: cystathionine synthase, inhibition, copper, chelation, homocysteine
Abstract: Copper was added to truncated, recombinant cystathionine β-synthase (CBS), and the enzyme activity was assessed by measuring the production of cystathionine. 10microM copper significantly decreased CBS activity by 50% while 25microM copper decreased CBS activity by 70%. This inhibition was negated when an analog of the N-terminus of human albumin, Asp-Ala-His-Lys (DAHK), a strong transition metal binding peptide, was added. The use of copper chelators could significantly reduce in vivo homocysteine levels.
Export Options
About this article
Cite this article as:
Bar-Or David, Rael T. Leonard, Thomas W. Gregory and Kraus P. Jan, Inhibitory Effect of Copper on Cystathionine β-Synthase Activity: Protective Effect of an Analog of the Human Albumin N-Terminus, Protein & Peptide Letters 2005; 12 (3) . https://dx.doi.org/10.2174/0929866053587048
DOI https://dx.doi.org/10.2174/0929866053587048 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Methods to Study Postprandial Lipemia
Current Vascular Pharmacology Ezetimibe and Vascular Endothelial Function
Current Vascular Pharmacology Functional Food: Product Development and Health Benefits
Recent Patents on Engineering The Role of Cnidaria in Drug Discovery. A Review on CNS Implications and New Perspectives
Recent Patents on CNS Drug Discovery (Discontinued) Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties
Current Pharmaceutical Design Patent Selections
Recent Patents on Cardiovascular Drug Discovery Small Molecules Modulating Biogenesis or Processing of microRNAs with Therapeutic Potentials
Current Medicinal Chemistry Nucleic Acid Drugs for Preventing Restenosis after Coronary Revascularization
Current Topics in Medicinal Chemistry The Diagnosis of Drug-Induced Liver Disease
Current Clinical Pharmacology Telemonitoring in the Management of High Blood Pressure
Current Pharmaceutical Design Evaluation of LVDD by CCTA with Dual-source CT in Type 2 Diabetes Mellitus Patients
Current Medical Imaging Rimonabant for the Treatment of Obesity
Recent Patents on Cardiovascular Drug Discovery The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
Cardiovascular & Hematological Disorders-Drug Targets Synthesis of New A-CD Estrogenic Compounds: D-Homo-analogs Lacking B-ring
Current Organic Chemistry α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Current Drug Targets Management of Osteoporosis: Seeing the Future
Medicinal Chemistry Reviews - Online (Discontinued) Molecular Basis of Antiretroviral Drugs-Associated Long-Term Toxicity: How Bad can Good Drugs Be?
Current Medicinal Chemistry - Anti-Infective Agents Recent Progress in Pharmacological Research of Antioxidants in Pathological Conditions: Cardiovascular Health
Recent Patents on Anti-Infective Drug Discovery Prophylactic Neuroprotection
Current Drug Targets Antithrombotic Therapy After TAVR
Current Vascular Pharmacology